|
1
|
Attele AS, Wu JA and Yuan CS: Ginseng
pharmacology: Multiple constituents and multiple actions. Biochem
Pharmacol. 58:1685–1693. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bak MJ, Jeong WS and Kim KB: Detoxifying
effect of fermented black ginseng on
H2O2-induced oxidative stress in HepG2 cells.
Int J Mol Med. 34:1516–1522. 2014.PubMed/NCBI
|
|
3
|
Wang JH, Nao JF, Zhang M and He P:
20(s)-ginsenoside Rg3 promotes apoptosis in human ovarian cancer
HO-8910 cells through PI3K/Akt and XIAP pathways. Tumour Biol.
35:11985–11994. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang P, Wei Y, Fan Y, Liu Q, Wei W, Yang
C, Zhang L, Zhao G, Yue J, Yan X and Zhou Z: Production of
bioactive ginsenosides Rh2 and Rg3 by metabolically engineered
yeasts. Metab Eng. 29:97–105. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kim HS, Lee EH, Ko SR, Choi KJ, Park JH
and Im DS: Effects of ginsenosides Rg3 and Rh2 on the proliferation
of prostate cancer cells. Arch Pharm Res. 27:429–435. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Park HM, Kim SJ, Kim JS and Kang HS:
Reactive oxygen species mediated ginsenoside Rg3- and Rh2-induced
apoptosis in hepatoma cells through mitochondrial signaling
pathways. Food Chem Toxicol. 50:2736–2741. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tang XP, Tang GD, Fang CY, Liang ZH and
Zhang LY: Effects of ginsenoside Rh2 on growth and migration of
pancreatic cancer cells. World J Gastroenterol. 19:1582–1592. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kim JW, Jung SY, Kwon YH, Lee JH, Lee YM,
Lee BY and Kwon SM: Ginsenoside Rg3 attenuates tumor angiogenesis
via inhibiting bioactivities of endothelial progenitor cells.
Cancer Biol Ther. 13:504–515. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Richardson RB: Promotional etiology for
common childhood acute lymphoblastic leukemia: The infective
lymphoid recovery hypothesis. Leuk Res. 35:1425–1431. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Vicente C and Cools J: The origin of
relapse In Pediatric T-Cell acute lymphoblastic leukemia.
Haematologica. 100:1373–1375. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Pui CH, Robison LL and Look AT: Acute
lymphoblastic leukemia. Lancet. 371:1030–1043. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Meleshko AN, Belevtsev MV, Savitskaja TV
and Potapnev MP: The incidence of T-cell receptor gene
rearrangements in childhood B-lineage acute lymphoblastic leukemia
is related to immunophenotype and fusion oncogene expression. Leuk
Res. 30:795–800. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Reed JC: Apoptosis-regulating proteins as
targets for drug discovery. Trends Mol Med. 7:314–319. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hengartner MO: The biochemistry of
apoptosis. Nature. 407:770–776. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ouyang L, Shi Z, Zhao S, Wang FT, Zhou TT,
Liu B and Bao JK: Programmed cell death pathways in cancer: A
review of apoptosis, autophagy and programmed necrosis. Cell
Prolif. 45:487–498. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chakraborty JB, Oakley F and Walsh MJ:
Mechanisms and biomarkers of apoptosis in liver disease and
fibrosis. Int J Hepatol. 2012:6489152012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Marchi S, Giorgi C, Suski JM, Agnoletto C,
Bononi A, Bonora M, De Marchi E, Missiroli S, Patergnani S, Poletti
F, et al: Mitochondria-ros crosstalk in the control of cell death
and aging. J Signal Transduct. 2012:3296352012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Indran IR, Hande MP and Pervaiz S: hTERT
overexpression alleviates intracellular ROS production, improves
mitochondrial function, and inhibits ROS-mediated apoptosis in
cancer cells. Cancer Res. 71:266–276. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cheng EH, Wei MC, Weiler S, Flavell RA,
Mak TW, Lindsten T and Korsmeyer SJ: Bcl-2, Bcl-X(L) sequester BH3
domain-only molecule spreventing BAX-and BAK-mediated mitochondrial
apoptosis. Mol Cell. 8:705–711. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kroemer G: The proto-oncogene Bcl-2 and
its role in regulating apoptosis. Nat Med. 3:614–620. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Murphy MP: How mitochondria produce
reactive oxygen species. Biochem J. 417:1–13. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shi Y: Mechanisms of caspase activation
and inhibition during apoptosis. Mol Cell. 9:459–470. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Choi JS, Chun KS, Kundu J and Kundu JK:
Biochemical basis of cancer chemoprevention and/or chemotherapy
with ginsenosides (Review). Int J Mol Med. 32:1227–1238.
2013.PubMed/NCBI
|
|
24
|
Bae EA, Han MJ, Kim EJ and Kim DH:
Transformation of ginseng saponins to ginsenoside Rh2 by acids and
human intestinal bacteria and biological activities of their
transformants. Arch Pharm Res. 27:61–67. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li J, Liu T, Zhao L, Chen W, Hou H, Ye Z
and Li X: Ginsenoside 20(S) Rg3 inhibits the Warburg effect through
STAT3 pathways in ovarian cancer cells. Int J Oncol. 46:775–781.
2015.PubMed/NCBI
|
|
26
|
Guo XX, Guo Q, Li Y, Lee SK, Wei XN and
Jin YH: Ginsenoside Rh2 induces human hepatoma cell apoptosis via
bax/bak triggered cytochrome c release and caspase-9/caspase-8
activation. Int J Mol Sci. 13:15523–15535. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang W, Wang H, Rayburn ER, Zhao Y, Hill
DL and Zhang R: 20(S)-25-methoxyldammarane-3beta, 12beta, 20-triol,
a novel natural product for prostate cancer therapy: Activity in
vitro and in vivo and mechanisms of action. Br J Cancer.
98:792–802. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cheong JH, Kim H, Hong MJ, Yang MH, Kim
JW, Yoo H, Yang H, Park JH, Sung SH, Kim HP and Kim J:
Stereoisomer-specific anticancer activities of ginsenoside Rg3 and
Rh2 in HepG2 Cells: Disparity in cytotoxicity and
autophagy-inducing effects due to 20(S)-epimers. Biol Pharm Bull.
38:102–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wu N, Wu GC, Hu R, Li M and Feng H:
Ginsenoside Rh2 inhibits glioma cell proliferation by targeting
microRNA-128. Acta Pharmacol Sin. 32:345–353. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Favaloro B, Allocati N, Graziano V, Di
Ilio C and De Laurenzi V: Role of apoptosis in disease. Aging
(Albany NY). 4:330–349. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Green DR and Kroemer G: Pharmacological
manipulation of cell death: Clinical applications in sight? J Clin
Invest. 115:2610–2617. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
32
|
Apel K and Hirt H: Reactive oxygen
species: Metabolism, oxidative stress, and signal transduction.
Annu Rev Plant Biol. 55:373–399. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Fujisawa S, Atsumi T, Ishihara M and
Kadoma Y: Cytotoxicity, ROS-generation activity and
radical-scavenging activity of curcumin and related compounds.
Anticancer Res. 24:563–569. 2004.PubMed/NCBI
|
|
34
|
Gogvadze V, Norberg E, Orrenius S and
Zhivotovsky B: Involvement of Ca2+ and ROS in alpha-tocopheryl
succinate-induced mitochondrial permeabilization. Int J Cancer.
127:1823–1832. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yadav N, Kumar S, Marlowe T, Chaudhary AK,
Kumar R, Wang J, O'Malley J, Boland PM, Jayanthi S, Kumar TK, et
al: Oxidative phosphorylation-dependent regulation of cancer cell
apoptosis in response to anticancer agents. Cell Death Dis.
6:e19692015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ola MS, Nawaz M and Ahsan H: Role of bcl-2
family proteins and caspases in the regulation of apoptosis. Mol
Cell Biochem. 351:41–58. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhou J, Zhang S, Ong CN and Shen HM:
Critical role of pro-apoptotic bcl-2 family members in
andrographolide-induced apoptosis in human cancer cells. Biochem
Pharmacol. 72:132–144. 2006. View Article : Google Scholar : PubMed/NCBI
|
